Status:
COMPLETED
Efficacy and Safety of Salmon Calcitonin Nasal Spray in Improving Muscle Strength and Reducing Pain After Forearm Fracture in Postmenopausal Women
Lead Sponsor:
Novartis
Conditions:
Forearm Fracture
Eligibility:
FEMALE
60+ years
Phase:
PHASE4
Brief Summary
Calcitonin has been used for many years for treating osteoporosis in postmenopausal women, and it has been shown that calcitonin reduces pain after spine and hip fracture in women with osteoporosis. T...
Eligibility Criteria
Inclusion
- Post-menopausal women, aged at least 60 years old
- Having a forearm fracture within the last 3-7 days before treatment
- Fracture is treated with either a plaster cast only, or a cast plus Kirschner wires
Exclusion
- Multiple fractures, severe fractures, or the forearm fractured in more than one place
- Nerve damage in the forearm caused by the fracture
- Other conditions which would interfere with the grip strength measurements (e.g. swelling, paralysis, skin diseases or rheumatoid arthritis)
- Other protocol-defined inclusion/exclusion criteria may apply.
Key Trial Info
Start Date :
March 1 2002
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00239889
Start Date
March 1 2002
Last Update
November 30 2006
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Novartis
Nuremberg, Germany
2
Novartis
Basel, Switzerland